Does BELATACEPT Cause Thrombotic microangiopathy? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Thrombotic microangiopathy have been filed in association with BELATACEPT (NULOJIX). This represents 1.6% of all adverse event reports for BELATACEPT.
56
Reports of Thrombotic microangiopathy with BELATACEPT
1.6%
of all BELATACEPT reports
11
Deaths
31
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From BELATACEPT?
Of the 56 reports, 11 (19.6%) resulted in death, 31 (55.4%) required hospitalization, and 9 (16.1%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELATACEPT. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which BELATACEPT Alternatives Have Lower Thrombotic microangiopathy Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN